CITIGROUP INC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$6,099,319
-12.6%
121,452
+9.9%
0.01%0.0%
Q2 2023$6,981,514
-21.7%
110,467
-44.3%
0.01%
-28.6%
Q1 2023$8,921,832
+48.3%
198,307
+44.4%
0.01%
+40.0%
Q4 2022$6,015,945
-48.3%
137,319
-22.2%
0.01%
-44.4%
Q3 2022$11,635,000
+80.1%
176,576
+38.1%
0.01%
+80.0%
Q2 2022$6,460,000
+340.1%
127,904
+456.5%
0.01%
+400.0%
Q1 2022$1,468,000
-78.3%
22,982
-63.6%
0.00%
-75.0%
Q4 2021$6,765,000
+11.3%
63,161
+6.9%
0.00%0.0%
Q3 2021$6,077,000
+10.7%
59,105
-5.3%
0.00%
+33.3%
Q2 2021$5,489,000
+27.4%
62,398
+40.7%
0.00%0.0%
Q1 2021$4,310,000
+168.9%
44,334
+210.0%
0.00%
+200.0%
Q4 2020$1,603,000
+161.1%
14,302
+116.1%
0.00%
Q3 2020$614,000
-78.0%
6,618
-81.5%
0.00%
-100.0%
Q2 2020$2,793,000
+16.8%
35,806
-12.4%
0.00%0.0%
Q1 2020$2,391,000
+33.4%
40,882
+82.8%
0.00%
+100.0%
Q4 2019$1,793,000
-10.8%
22,369
-18.2%
0.00%
-50.0%
Q3 2019$2,010,000
-70.9%
27,361
-62.7%
0.00%
-66.7%
Q2 2019$6,914,000
+223.1%
73,287
+174.2%
0.01%
+200.0%
Q1 2019$2,140,000
-72.0%
26,731
-81.1%
0.00%
-75.0%
Q4 2018$7,633,000
-46.2%
141,594
-22.1%
0.01%
-38.5%
Q3 2018$14,181,000
+15.7%
181,670
-5.9%
0.01%
+18.2%
Q2 2018$12,258,000
+21405.3%
193,104
+30747.3%
0.01%
Q1 2018$57,000
+111.1%
626
+72.5%
0.00%
Q4 2017$27,000
-98.7%
363
-98.8%
0.00%
-100.0%
Q3 2017$2,048,000
+12.5%
29,395
-18.2%
0.00%0.0%
Q2 2017$1,821,000
+239.7%
35,948
+168.0%
0.00%
Q1 2017$536,000
-71.0%
13,412
-79.6%
0.00%
-100.0%
Q4 2016$1,847,000
+872.1%
65,854
+927.2%
0.00%
Q3 2016$190,000
+48.4%
6,411
+1.5%
0.00%
Q2 2016$128,000
-37.6%
6,318
-44.3%
0.00%
Q1 2016$205,000
-90.9%
11,351
-86.7%
0.00%
-100.0%
Q4 2015$2,243,000
+37.4%
85,163
+11.3%
0.00%0.0%
Q3 2015$1,633,000
+40725.0%
76,495
+52655.2%
0.00%
Q2 2015$4,0001450.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders